March 12, 2019 ARCH News from ARCH Venture Partners | Share ARCH Receives NVCA Firm Of The Year Award
March 6, 2019 Portfolio News from ARCH Venture Partners | Share Gene editing startup Beam Therapeutics raises $135M Series B round
March 5, 2019 Portfolio News from ARCH Venture Partners | Share Erasca™- AI Oncology Startup Announces Series A Extension
March 1, 2019 Portfolio News from ARCH Venture Partners | Share Maze Therapeutics Launches to Focus on Translating Genetic Insights into New Medicines
February 7, 2019 Portfolio News from ARCH Venture Partners | Share New York Biotech Raises $61 Million To Keep Cancer Cells Dormant, Bucking Conventional Treatments
February 7, 2019 Portfolio News from ARCH Venture Partners | Share Gossamer Bio pulls off $276M IPO to push a trio of programs through the clinic
